Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

La Jolla Pharmaceutical Company patents


Recent patent applications related to La Jolla Pharmaceutical Company. La Jolla Pharmaceutical Company is listed as an Agent/Assignee. Note: La Jolla Pharmaceutical Company may have other listings under different names/spellings. We're not affiliated with La Jolla Pharmaceutical Company, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | La Jolla Pharmaceutical Company-related inventors


Methods of treating iron overload

Provided herein are compositions and methods related to the use of hepcidin and/or hepcidin analogues for the treatment and/or prevention of iron overload in a subject (e.g., a human subject) and/or for reducing serum iron levels in a subject without inducing serum iron rebound.. . ... La Jolla Pharmaceutical Company

Methods of administering hepcidin

The present disclosure relates to the use of hepcidin in therapeutic methods for the treatment of various conditions in which decreasing serum iron concentration may be beneficial.. . ... La Jolla Pharmaceutical Company

Methods for administering angiotensin ii

The present disclosure relates to the use of angiotensin ii, angiotensin iii, or angiotensin iv in therapeutic methods for the treatment of hypotension, especially catecholamine-resistant hypotension.. . ... La Jolla Pharmaceutical Company

Compositions and methods related to gentamicin

Various aspects of the invention relate to compositions comprising c-2a gentamicin. A composition may be substantially free from one or more of c-1 gentamicin, c-1a gentamicin, c-2 gentamicin, c-2b gentamicin, gentamicin a, gentamicin b, and gentamicin x. ... La Jolla Pharmaceutical Company

Compositions and methods for treating renal failure

The present disclosure relates to the use of angiotensin ii in therapeutic methods for the treatment of renal failure, especially renal failure associated with cirrhosis.. . ... La Jolla Pharmaceutical Company

Compositions and methods for administering galectin antagonists

The invention provides methods for the treatment of diseases and conditions relating to galectin 3 using a galectin-3 inhibitor, such as a modified pectin (e.g., gcs-100). Also described are methods for conjoint therapy, and methods for assessing and/or monitoring the effects of a galectin-3 inhibitor, e.g., to adapt the dosing regimen of the inhibitor during therapy.. ... La Jolla Pharmaceutical Company








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with La Jolla Pharmaceutical Company in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for La Jolla Pharmaceutical Company with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###